Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fibrotic disorder of the lung parenchyma. We have demonstrated changes in IL-10 protein production by alveolar macrophages (AMs) from patients with IPF, which we hypothesise could be because of an IL-10 gene polymorphism. We have screened the coding sequence and 3′ untranslated region of IL-10 for polymorphisms using single-standard conformational polymorphism analysis. A novel polymorphism was identified resulting in a G to A substitution of +43 nucleotides from the start codon changing glycine to arginine at amino acid 15 of the signal peptide sequence. We have introduced the signal peptide mutation into the IL-10 gene and compared secretion of the mutant and wild-type forms after transient transfection of COS-7 cells. Our studies showed that the signal peptide mutation did not have a significant effect on secretion at 24 h post-transfection (P=0.4529 by Mann-Whitney test). However, by 48 h there are significantly lower levels of mutant IL-10 (P=0.0515). There were no differences in the level of cell-associated IL-10 at either 24 or 48 h (P=0.9296 and 0.4268). We suggest that the mutation could affect the efficiency of protein translocation and signal peptide cleavage resulting in lower levels of IL-10 protein secretion.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Nathan CF . Secretory products of macrophages. J Clin Invest 1987; 79: 319–326.
Tracey KJ, Cerami A . Tumour necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 1994; 45: 491–503.
Piguet PF, Grau GE, Vassalli P . Subcutaneous perfusion of tumour necrosis factor induces local proliferation of fibroblasts, capillaries and epidermal cells or massive tumour necrosis. Am J Pathol 1990; 136: 103–110.
Wanidworanun C, Strober W . Predominant role of tumour necrosis factor-alpha in human monocyte IL-10 synthesis. J Immunol 1993; 151: 6853–6861.
Armstrong L, Jordan N, Millar A . Interleukin 10 (IL-10) regulation of tumour necrosis factor alpha (TNF-alpha) from human alveolar macrophages and peripheral blood monocytes. Thorax 1996; 51: 143–149.
Martinez JA, King TE, Brown K et al. Increased expression of the interleukin-10 gene by alveolar macrophages in interstitial lung disease. Am J Physiol 1997; 273: L676–L683.
Zhang Y, Lee TC, Guillemin B, Yu M, Rom WN . Enhanced IL-10 and tumour necrosis factor-a release and messenger RNA expression in macrophages from idiopathic fibrosis or after asbestos exposure. J Immunol 1993; 150: 4188–4196.
Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW . Interleukin 10 secretion in relation to IL-10 locus haplotypes. Proc Natl Acad Sci USA 1998; 95: 9465–9470.
Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV . An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1–8.
Donger C, Georges JL, Nicaud V et al. New polymorphisms in the interleukin-10 gene-relationships to myocardial infarction. Eur J Clin Invest 2001; 31: 9–14.
Martoglio B, Dobberstein B . Signal sequences: more than just greasy peptides. Trends Cell Biol 1998; 8: 410–415.
Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV . Genotypic variation in the transforming growth factor-beta 1 gene: association with transforming growth factor-beta 1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998; 66: 1014–1020.
Ito M, Oiso Y, Murase T et al. Possible involvement of inefficient cleavage of preprovassopressin by signal peptidase as a cause for familial central diabetes insipidus. J Clin Invest 1993; 91: 2565–2571.
Racchi M, Watzke HH, High KA, Lively MO . Human coagulation factor X deficiency caused by a mutant signal peptide that blocks cleavage by signal peptidase but not targeting and translocation to the endoplasmic reticulum. J Biol Chem 1993; 268: 5735–5740.
Zschenker O, Jung N, Rethmeier J et al. Characterization of lysosomal acid lipase mutations in the signal peptide and mature polypeptide region causing Wolman disease. J Lipid Res 2001; 42: 1033–1040.
Karaplis AC, Lim S, Baba H, Arnold A, Kronenberg HM . Inefficient membrane targeting, translocation and proteolytic processing by signal peptidase of a mutant preproparathyroid hormone protein. J Biol Chem 1995; 270: 1629–1635.
Schwacha MG, Schneider CP, Bland KI, Chaudry IH . Resistance of macrophages to the suppressive effect of interleukin-10 following thermal injury. Am J Physiol Cell Physiol 2001; 281: C1180–C1187.
Avdiushko R, Hongo D, Lake-Bullock H, Kaplan A, Cohen D . IL-10 receptor dysfunction in macrophages during chronic inflammation. J Leuk Biol 2001; 70: 624–632.
Demedts M, Costabel U . ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Eur Respir J 2002; 19: 794–796.
Gustincich S, Manfioletti G, Del Sal G, Schneider C, Carninci P . A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques 1991; 11: 298–300.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Whittington, H., Freeburn, R., Godinho, S. et al. Analysis of an IL-10 polymorphism in idiopathic pulmonary fibrosis. Genes Immun 4, 258–264 (2003). https://doi.org/10.1038/sj.gene.6363959
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gene.6363959
Keywords
This article is cited by
-
Whole-exome sequencing identifies susceptibility genes and pathways for idiopathic pulmonary fibrosis in the Chinese population
Scientific Reports (2021)
-
Sequence variation of Epstein-Barr virus (EBV) BCRF1 in lymphomas in non-endemic areas of nasopharyngeal carcinoma
Archives of Virology (2015)
-
Association of FcγRIIa R131H polymorphism with idiopathic pulmonary fibrosis severity and progression
BMC Pulmonary Medicine (2010)
-
Fcγ Receptor IIIb (CD16b) Polymorphisms are Associated with Susceptibility to Idiopathic Pulmonary Fibrosis
Lung (2010)